Showing 61 - 70 of 197,097
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry, however only a few biosimilars have been approved in the US since 2015, thereby largely preserving biologics...
Persistent link: https://www.econbiz.de/10014126235
Future Elderly Model (EuFEM), a dynamic microsimulation model which projects the health and socio-economic characteristics of …
Persistent link: https://www.econbiz.de/10012956880
of inclusiveness with respect to vulnerable elderly's health status. Focusing on several European countries, this paper … that substantial heterogeneities exist both at the extensive margin (the health-outcomes that are included in the …
Persistent link: https://www.econbiz.de/10013039883
Very few industries are as profoundly influenced by regulation as the pharmaceutical industry. All aspects of the life-cycle of new drugs are regulated, from patent application, to marketing approval, commercial exploitation, patent expiration and competition with generics. The nature of demand...
Persistent link: https://www.econbiz.de/10012980141
the European Commission within the broader framework of EU economic law and then evaluates the compatibility of the public …
Persistent link: https://www.econbiz.de/10014031286
Prescription drug expenditures make up less than 10 percent of total personal health care expenditures in the United … component of personal health care. For example, between 1999 and 2000, hospital care costs rose about 5 percent, physicians and … clinical services 6 percent, while prescription drug expenditures climbed more than 17 percent. In dollar amounts, prescription …
Persistent link: https://www.econbiz.de/10013126058
, since southern European countries generally have lower prices. Due to the possibilities for parallel trade within the EU …
Persistent link: https://www.econbiz.de/10003471161
Persistent link: https://www.econbiz.de/10012167600
Persistent link: https://www.econbiz.de/10011384620
cohorts to the health status enjoyed by Europeans could save up to $1.1 trillion in discounted total health expenditures from … primarily the symptom of real declines in the health of near-elderly Americans, relative to their European peers. In particular …, we use a microsimulation approach to project what US longevity would look like, if US health trends approximated those in …
Persistent link: https://www.econbiz.de/10014200788